Early discontinuation of endocrine therapy and recurrence of breast cancer among premenopausal women.

CONCLUSION: These results highlight the importance of clinical follow-up and behavioral interventions that support persistence of adjuvant endocrine therapy to prevent breast cancer recurrence.
PMID: 33334905 [PubMed - as supplied by publisher]

Source: Clinical Cancer Research - December 17, 2020 Category: Cancer & Oncology Authors: Collin LJ, Cronin-Fenton D, Ahern TP, Goodman M, McCullough LE, Waller LA, Kjærsgaard A, Damkier P, Christiansen PM, Ejlertsen B, Jensen MB, Sorensen HT, Lash TL Tags: Clin Cancer Res Source Type: research